Pulmonary artery pseudoaneurysms (PAPs) in Hughes-Stovin syndrome (HSS) as an emerging concept for a potentially fatal course

IF 1 Q4 RHEUMATOLOGY
Tubig C. Joy , Juljani Sherwina , Ayuyao Fernando , Ma E Limpin , Ma Paz Mateo , Khalid Alhusseiny
{"title":"Pulmonary artery pseudoaneurysms (PAPs) in Hughes-Stovin syndrome (HSS) as an emerging concept for a potentially fatal course","authors":"Tubig C. Joy ,&nbsp;Juljani Sherwina ,&nbsp;Ayuyao Fernando ,&nbsp;Ma E Limpin ,&nbsp;Ma Paz Mateo ,&nbsp;Khalid Alhusseiny","doi":"10.1016/j.ejr.2023.03.004","DOIUrl":null,"url":null,"abstract":"<div><h3>Introduction</h3><p>Hughes-Stovin syndrome (HSS) is a systemic vasculitis characterized by pulmonary artery aneurysms (PAA) and widespread venous and arterial thrombosis. Fatalities in HSS resulted from unforeseeable fatal suffocating hemoptysis. It is critical to early detect pulmonary involvement to take timely measures against inevitable serious life-threatening complications.</p></div><div><h3>Case presentation</h3><p>A 27 year old Filipino male patient presented to the emergency department with an acute attack of massive hemoptysis. The markers of inflammation were elevated with anemia and a normal coagulation profile. The patient had bilateral lower limb edema with tender calf muscles. Color Doppler ultrasound revealed bilateral deep vein thrombosis. Importantly, an urgent computerized tomography pulmonary angiography (CTPA) revealed bilateral large PAAs which matched the pattern of pseudoaneurysms described by the HSS international study group (HSSISG). There was no history of iridocyclitis, recurrent oral or genital ulcers. Accordingly, the patient was diagnosed with HSS. The patient received intravenous pulse methylprednisolone (1 g/3 days), then oral prednisone (1 mg/kg/d/3 months), and monthly pulse cyclophosphamide (1 g) for three months. The patient remained symptom-free, yet on the third pulse of cyclophosphamide; he patient contracted corona virus disease-2019 (COVID-19) infection and died three weeks later from a fatal episode of massive hemoptysis. The case was discussed and the recent literature was reviewed relative to fatal hemoptysis associated with pulmonary artery pseudoaneurysms (PAPs) pattern in HSS</p></div><div><h3>Conclusion</h3><p>HSS presenting with massive hemoptysis could be lifethreatening and the PAPs are considered a double edged sword. Detailed description of such rare cases is warranted for optimum future management.</p></div>","PeriodicalId":46152,"journal":{"name":"Egyptian Rheumatologist","volume":null,"pages":null},"PeriodicalIF":1.0000,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Egyptian Rheumatologist","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1110116423000182","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"RHEUMATOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction

Hughes-Stovin syndrome (HSS) is a systemic vasculitis characterized by pulmonary artery aneurysms (PAA) and widespread venous and arterial thrombosis. Fatalities in HSS resulted from unforeseeable fatal suffocating hemoptysis. It is critical to early detect pulmonary involvement to take timely measures against inevitable serious life-threatening complications.

Case presentation

A 27 year old Filipino male patient presented to the emergency department with an acute attack of massive hemoptysis. The markers of inflammation were elevated with anemia and a normal coagulation profile. The patient had bilateral lower limb edema with tender calf muscles. Color Doppler ultrasound revealed bilateral deep vein thrombosis. Importantly, an urgent computerized tomography pulmonary angiography (CTPA) revealed bilateral large PAAs which matched the pattern of pseudoaneurysms described by the HSS international study group (HSSISG). There was no history of iridocyclitis, recurrent oral or genital ulcers. Accordingly, the patient was diagnosed with HSS. The patient received intravenous pulse methylprednisolone (1 g/3 days), then oral prednisone (1 mg/kg/d/3 months), and monthly pulse cyclophosphamide (1 g) for three months. The patient remained symptom-free, yet on the third pulse of cyclophosphamide; he patient contracted corona virus disease-2019 (COVID-19) infection and died three weeks later from a fatal episode of massive hemoptysis. The case was discussed and the recent literature was reviewed relative to fatal hemoptysis associated with pulmonary artery pseudoaneurysms (PAPs) pattern in HSS

Conclusion

HSS presenting with massive hemoptysis could be lifethreatening and the PAPs are considered a double edged sword. Detailed description of such rare cases is warranted for optimum future management.

Hughes-Stovin综合征(HSS)中的肺动脉假性动脉瘤(PAPs)是一种潜在致命过程的新兴概念
休斯-斯托文综合征(HSS)是一种以肺动脉瘤(PAA)和广泛的静脉和动脉血栓形成为特征的系统性血管炎。HSS的死亡是由不可预见的致命窒息性咳血引起的。早期发现肺部受累,及时采取措施预防不可避免的严重危及生命的并发症,这一点至关重要。病例介绍:一名27岁的菲律宾男性患者因大咯血急性发作而被送往急诊科。炎症标志物随着贫血和正常凝血而升高。患者双侧下肢水肿,小腿肌肉酸痛。彩色多普勒超声显示双侧深静脉血栓形成。重要的是,紧急计算机断层扫描肺血管造影术(CTPA)显示双侧大PAA与HSS国际研究小组(HSSISG)描述的假性动脉瘤模式相匹配。没有虹膜睫状体炎、复发性口腔或生殖器溃疡的病史。因此,患者被诊断为HSS。患者接受静脉注射甲基强的松龙(1g/3天),然后口服泼尼松(1mg/kg/d/3个月),每月注射环磷酰胺(1g),持续3个月。患者仍然没有症状,但接受了环磷酰胺的第三次注射;该患者感染了2019冠状病毒病(新冠肺炎),三周后死于致命的大咳血。对该病例进行了讨论,并回顾了与HSSC中肺动脉假性动脉瘤(PAPs)模式相关的致命性咳血的最新文献。结论HSS表现为大量咳血可能会危及生命,PAPs被认为是一把双刃剑。对这种罕见情况的详细描述是有必要的,以优化未来的管理。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Egyptian Rheumatologist
Egyptian Rheumatologist RHEUMATOLOGY-
CiteScore
2.00
自引率
22.20%
发文量
77
审稿时长
39 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信